Reoperations for myocardial revascularization
Reoperations solely for myocardial revascularization were performed in 219 consecutive patients (1967 to 1975). Indications were (1) graft failure, 46 (21 per cent); (2) progressive atherosclerosis, 42 (19 per cent); (3) incomplete revascularization, 39 (18 per cent); and (4) combinations, 92 (42 per cent).
Paul C. Taylor +5 more
openaire +3 more sources
Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis [PDF]
PMCID: PMC3686792This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
A Abdel-Latif +32 more
core +3 more sources
Myocardial Viability Testing in Patients with Ischemic Cardiomyopathy [PDF]
Ischemic cardiomyopathy (ICM) is an important cause of heart failure with reduced ejection fraction. Despite the improvement of treatment methods, it still has a high mortality.
SU Lifang, WANG Yanbo, JIANG Yunfa, LIU Changchang, GU Xinshun
doaj +1 more source
Meta-analysis of death and myocardial infarction in the DEFINE-FLAIR and iFR-SWEDEHEART trials: a hypothesis generating note of caution [PDF]
In patients with coronary heart disease, revascularization can improve symptoms and in certain high-risk subgroups may improve prognosis. Coronary angiography provides anatomical information and the physiological significance of a stenosis can be ...
Berry, Colin +2 more
core +1 more source
BackgroundRehospitalizations following acute myocardial infarction for unplanned coronary revascularization and unstable angina (UA) are often included as parts of composite end points in clinical trials.
Supriya Shore +7 more
doaj +1 more source
Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention [PDF]
Objective: We hypothesised that, compared with culprit-only primary percutaneous coronary intervention (PCI), additional preventive PCI in selected patients with ST-elevation myocardial infarction with multivessel disease would not be associated with ...
Berry, Colin +13 more
core +1 more source
Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. [PDF]
BackgroundElevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown.Methods and resultsBaseline demographics and 2-year MACE were ...
Ang, Lawrence +7 more
core +1 more source
Myocardial protection during myocardial revascularization: Preductal®MR
Myocardial revascularization procedures (coronary artery bypass surgery, percutaneous coronary intervention) raise the question of protecting the myocardium. Trimetazidine is an adequate method of myocardial protection.
Editorial Article
doaj +1 more source
Many patients with non-ST elevation myocardial infarction have multivessel coronary artery disease, which complicates the course of the disease and is associated with fatal outcomes.
Sh. J. Khalilov, V. A. Azizov
doaj +1 more source
Myocardial revascularization in renal transplant patients
OBJECTIVE: To assess the results of surgical myocardial revascularization in renal transplant patients. METHODS: From 1991 to 2000, 11 renal transplant patients, whose ages ranged from 36 to 59 (47.5±8) years, 8 males and 3 females, underwent ...
Daniel de Souza Delgado +4 more
doaj +1 more source

